Tag Archives: faux

Bayh-Dole Basics, 4: contractor comments

Bayh-Dole defines anyone on the other side of a funding agreement from a federal agency as a contractor.  The term is arbitrary and misleading. Let’s look at both aspects. The standard patent rights clause requires the contractors that host federally … Continue reading

Posted in Bayh-Dole | Tagged , , , , , , , , , | Comments Off on Bayh-Dole Basics, 4: contractor comments

A New Guide to Bayh-Dole–Outline Version

Here’s an alternative guide to Bayh-Dole and its doppleganger faux Bayh-Dole. There’s a whole book in here, but I’ve left out the chapter and verse documentation and the historical evidence and interviews and the like. This is not the version … Continue reading

Posted in Bayh-Dole | Tagged , , | Comments Off on A New Guide to Bayh-Dole–Outline Version

The NIH’s complicity in faux Bayh-Dole and high drug prices

Here’s “A ’20-20′ View of Invention Reporting to the National Institutes of Health”–published by the NIH in 1995. 2. WHAT IS THE BAYH-DOLE ACT AND WHY IS IT IMPORTANT? The Bayh-Dole Act encourages researchers to patent and market their inventions … Continue reading

Posted in Bayh-Dole, History, Stanford v Roche | Tagged , , , , | Comments Off on The NIH’s complicity in faux Bayh-Dole and high drug prices

Senator Bayh’s inventor-loathing faux Bayh-Dole Act

There has been plenty written about the practice lesson taught by the Supreme Court decision in Stanford v Roche. I’m dismayed how much of it shows no evidence of an awareness of the facts of the case and the primary … Continue reading

Posted in Bayh-Dole, Policy, Stanford v Roche | Tagged , , , , , | 1 Comment